For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Kyverna Therapeutics Inc’s stock clocked out at $6.88, down -1.29% from its previous closing price of $6.97. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 0.72 million shares were traded. KYTX stock price reached its highest trading level at $7.1922 during the session, while it also had its lowest trading level at $6.61.
Ratios:
To gain a deeper understanding of KYTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 27, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $13.UBS initiated its Buy rating on October 10, 2024, with a $13 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYTX now has a Market Capitalization of 297530208 and an Enterprise Value of 91771192.
Stock Price History:
The Beta on a monthly basis for KYTX is 3.82, which has changed by 0.36935163 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, KYTX has reached a high of $8.45, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is 21.58%, while the 200-Day Moving Average is calculated to be 93.03%.
Shares Statistics:
It appears that KYTX traded 557.07K shares on average per day over the past three months and 828390 shares per day over the past ten days. A total of 43.24M shares are outstanding, with a floating share count of 21.32M. Insiders hold about 50.70% of the company’s shares, while institutions hold 25.31% stake in the company. Shares short for KYTX as of 1760486400 were 1577306 with a Short Ratio of 2.83, compared to 1757894400 on 1608183. Therefore, it implies a Short% of Shares Outstanding of 1577306 and a Short% of Float of 6.35.
Earnings Estimates
The firm’s stock currently is rated by 5.0 analysts. The consensus estimate for the next quarter is -$0.87, with high estimates of -$0.6 and low estimates of -$1.04.
Analysts are recommending an EPS of between -$3.35 and -$4.04 for the fiscal current year, implying an average EPS of -$3.78. EPS for the following year is -$3.54, with 5.0 analysts recommending between -$2.96 and -$4.21.
